## **Core Concept**
The question tests knowledge of lipid-lowering drugs and their effects on lipoprotein(a) [Lp(a)] levels. Lp(a) is a type of lipoprotein that transports cholesterol in the blood and is considered a risk factor for cardiovascular diseases. Certain lipid-lowering therapies can have varying effects on Lp(a) levels.

## **Why the Correct Answer is Right**
Niacin (or nicotinic acid) is known to have a unique effect among lipid-lowering drugs; it can significantly increase levels of lipoprotein(a) [Lp(a)], despite its beneficial effects on other lipid profiles, such as increasing HDL cholesterol and reducing triglycerides and LDL cholesterol. This effect is not fully understood but is a recognized side effect of niacin therapy.

## **Why Each Wrong Option is Incorrect**
- **Option A:** Statins generally decrease Lp(a) levels slightly or have a minimal effect, making this option incorrect.
- **Option B:** Bile acid sequestrants can have variable effects on Lp(a), but they are not specifically known for increasing Lp(a) levels; they are more associated with changes in LDL and HDL levels.
- **Option C:** This option is not provided, but based on the correct answer being , we can infer that the other options do not significantly increase Lp(a) levels.
- **Option D:** This option is also not provided, but similar to option C, it would not be correct based on the information given.

## **Clinical Pearl / High-Yield Fact**
A key point to remember is that niacin can increase Lp(a) levels, which might limit its use in patients with very high Lp(a) levels, despite its favorable effects on other aspects of the lipid profile. This is a critical consideration in the management of patients with dyslipidemia.

## **Correct Answer:** .